CAS 1564265-94-6

(1R,3R,5R,2'S)-Saxagliptin

CAS : 1564265-94-6

Formule : C₁₈H₂₅N₃O₂

Masse moléculaire : 315.42

Ref: 4Z-S-3227

(2’S,2R,cis)-Saxagliptin

Produit contrôlé

CAS : 1564265-94-6

Formule : C₁₈H₂₅N₃O₂

Couleur et forme : Neat

Masse moléculaire : 315.41

Ref: TR-S143485

(2S,2R,Cis)-saxagliptin

CAS : 1564265-94-6

(2S,2R,Cis)-saxagliptin is a drug product that has been developed for the treatment of type II diabetes. It is an orally active DPP-4 inhibitor that inhibits the degradation of GLP-1 and GIP and lowers blood glucose levels in patients with type II diabetes mellitus. It binds to the serine/threonine protein phosphatase catalytic site of DPP-4. (2S,2R,Cis)-saxagliptin can be used as a standard for HPLC analysis and as a research and development compound in the study of its metabolism. This drug product is not on the World Health Organization's list of essential medicines. (2S,2R,Cis)-saxagliptin is also not on the United States Pharmacopeia’s list of approved drugs.

Formule : C₁₈H₂₅N₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 315.40 g/mol

Ref: 3D-PMC26594

(2’S,2R,Cis)-Saxagliptin

CAS : 1564265-94-6

Formule : C₁₈H₂₅N₃O₂

Masse moléculaire : 315.42

Ref: ST-EA-CP-S19043